---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-054782"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:48:58.788297+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# NeuroOne amends bylaws: reduces stockholder quorum to one-third, updates proxy rules

## Summary
- Stockholder quorum reduced from majority to one-third of outstanding voting power.
- New universal proxy compliance requirement under SEC Rule 14a-19 for director nominations.
- Enhanced disclosure obligations for stockholder nominations and proposals, including derivative interests.
- Special meeting nominators must hold 10% of voting power and be stockholder at notice and record dates.
- Clarified personal jurisdiction and service of process for foreign actions.

## SEC filing metadata
- accession: 0001213900-24-054782
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390024054782/0001213900-24-054782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390024054782/ea0208217-8k_neuro.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-054782
- JSON: https://secwatch.observer/filing/0001213900-24-054782.json
- Plain text: https://secwatch.observer/filing/0001213900-24-054782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.